First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07) (English)
- New search for: von Moos, R.
- New search for: Seifert, B.
- New search for: Simcock, M.
- New search for: Goldinger, S. M.
- New search for: Gillessen, S.
- New search for: Ochsenbein, A.
- New search for: Michielin, O.
- New search for: Cathomas, R.
- New search for: Schlappi, M.
- New search for: Moch, H.
- New search for: von Moos, R.
- New search for: Seifert, B.
- New search for: Simcock, M.
- New search for: Goldinger, S. M.
- New search for: Gillessen, S.
- New search for: Ochsenbein, A.
- New search for: Michielin, O.
- New search for: Cathomas, R.
- New search for: Schlappi, M.
- New search for: Moch, H.
In:
ANNALS OF ONCOLOGY
;
23
, 2
;
531-536
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
-
Contributors:von Moos, R. ( author ) / Seifert, B. ( author ) / Simcock, M. ( author ) / Goldinger, S. M. ( author ) / Gillessen, S. ( author ) / Ochsenbein, A. ( author ) / Michielin, O. ( author ) / Cathomas, R. ( author ) / Schlappi, M. ( author ) / Moch, H. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 2 ; 531-536
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 283
-
Heine H. Hansen, 1938-2011: a European oncologistTonato, M. et al. | 2012
- 285
-
Screening mammography and socioeconomic inequalities in breast cancer survivalWoods, L. M. / Sasieni, P. / Rachet, B. et al. | 2012
- 287
-
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma riskTramacere, I. / Pelucchi, C. / Bagnardi, V. / Rota, M. / Scotti, L. / Islami, F. / Corrao, G. / Boffetta, P. / La Vecchia, C. / Negri, E. et al. | 2012
- 298
-
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomesGreco, F. A. / Oien, K. / Erlander, M. / Osborne, R. / Varadhachary, G. / Bridgewater, J. / Cohen, D. / Wasan, H. et al. | 2012
- 305
-
CMF revisited in the 21st centuryMunzone, E. / Curigliano, G. / Burstein, H. J. / Winer, E. P. / Goldhirsch, A. et al. | 2012
- 311
-
A meta-analysis of coffee consumption and pancreatic cancerTurati, F. / Galeone, C. / Edefonti, V. / Ferraroni, M. / Lagiou, P. / La Vecchia, C. / Tavani, A. et al. | 2012
- 319
-
Does an organised screening programme reduce the inequalities in breast cancer survival?Puliti, D. / Miccinesi, G. / Manneschi, G. / Buzzoni, C. / Crocetti, E. / Paci, E. / Zappa, M. et al. | 2012
- 324
-
Breast cancer subtypes and outcome after local and regional relapseMontagna, E. / Bagnardi, V. / Rotmensz, N. / Viale, G. / Renne, G. / Cancello, G. / Balduzzi, A. / Scarano, E. / Veronesi, P. / Luini, A. et al. | 2012
- 331
-
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology GroupMiller, K. D. / O'Neill, A. / Perez, E. A. / Seidman, A. D. / Sledge, G. W. et al. | 2012
- 338
-
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcomeYerushalmi, R. / Tyldesley, S. / Kennecke, H. / Speers, C. / Woods, R. / Knight, B. / Gelmon, K. A. et al. | 2012
- 346
-
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)Lortholary, A. / Largillier, R. / Weber, B. / Gladieff, L. / Alexandre, J. / Durando, X. / Slama, B. / Dauba, J. / Paraiso, D. / Pujade-Lauraine, E. et al. | 2012
- 353
-
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experienceWozniak, A. / Rutkowski, P. / Piskorz, A. / Ciwoniuk, M. / Osuch, C. / Bylina, E. / Sygut, J. / Chosia, M. / Rys, J. / Urbanczyk, K. et al. | 2012
- 361
-
External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancerKim, J. H. / Kim, H. S. / Seo, W. Y. / Nam, C. M. / Kim, K. Y. / Jeung, H. C. / Lai, J. F. / Chung, H. C. / Noh, S. H. / Rha, S. Y. et al. | 2012
- 367
-
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancersHaan, J. C. / Buffart, T. E. / Eijk, P. P. / van de Wiel, M. A. / van Wieringen, W. N. / Howdle, P. D. / Mulder, C. J. / van de Velde, C. J. / Quirke, P. / Nagtegaal, I. D. et al. | 2012
- 374
-
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)Lucenteforte, E. / La Vecchia, C. / Silverman, D. / Petersen, G. M. / Bracci, P. M. / Ji, B. T. / Bosetti, C. / Li, D. / Gallinger, S. / Miller, A. B. et al. | 2012
- 382
-
Lung cancer physicians' referral practices for palliative care consultationSmith, C. B. / Nelson, J. E. / Berman, A. R. / Powell, C. A. / Fleischman, J. / Salazar-Schicchi, J. / Wisnivesky, J. P. et al. | 2012
- 388
-
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyCoudert, B. / Ciuleanu, T. / Park, K. / Wu, Y. L. / Giaccone, G. / Brugger, W. / Gopalakrishna, P. / Cappuzzo, F. et al. | 2012
- 395
-
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registryBuchler, T. / Klapka, R. / Melichar, B. / Brabec, P. / Dusek, L. / Vyzula, R. / Abrahamova, J. et al. | 2012
- 401
-
The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean populationYun, S. J. / Ha, Y. S. / Chae, Y. / Kim, J. S. / Kim, I. Y. / Kim, W. J. et al. | 2012
- 406
-
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinomaGalsky, M. D. / Chen, G. J. / Oh, W. K. / Bellmunt, J. / Roth, B. J. / Petrioli, R. / Dogliotti, L. / Dreicer, R. / Sonpavde, G. et al. | 2012
- 411
-
Risk of second cancers in Waldenstrom macroglobulinemiaVarettoni, M. / Tedeschi, A. / Arcaini, L. / Pascutto, C. / Vismara, E. / Orlandi, E. / Ricci, F. / Corso, A. / Greco, A. / Mangiacavalli, S. et al. | 2012
- 415
-
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaZinzani, P. L. / Tani, M. / Pulsoni, A. / De Renzo, A. / Stefoni, V. / Broccoli, A. / Montini, G. C. / Fina, M. / Pellegrini, C. / Gandolfi, L. et al. | 2012
- 421
-
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infectionMya, D. H. / Han, S. T. / Linn, Y. C. / Hwang, W. Y. / Goh, Y. T. / Tan, D. C. et al. | 2012
- 427
-
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationFountzilas, G. / Ciuleanu, E. / Bobos, M. / Kalogera-Fountzila, A. / Eleftheraki, A. G. / Karayannopoulou, G. / Zaramboukas, T. / Nikolaou, A. / Markou, K. / Resiga, L. et al. | 2012
- 435
-
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical resultsSecondino, S. / Zecca, M. / Licitra, L. / Gurrado, A. / Schiavetto, I. / Bossi, P. / Locati, L. / Schiavo, R. / Basso, S. / Baldanti, F. et al. | 2012
- 442
-
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II studyKotsakis, A. / Vetsika, E. K. / Christou, S. / Hatzidaki, D. / Vardakis, N. / Aggouraki, D. / Konsolakis, G. / Georgoulias, V. / Christophyllakis, C. / Cordopatis, P. et al. | 2012
- 450
-
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyRousseau, B. / Loulergue, P. / Mir, O. / Krivine, A. / Kotti, S. / Viel, E. / Simon, T. / de Gramont, A. / Goldwasser, F. / Launay, O. et al. | 2012
- 458
-
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experienceKhasraw, M. / Holodny, A. / Goldlust, S. A. / DeAngelis, L. M. et al. | 2012
- 463
-
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsSoria, J. C. / Cortes, J. / Massard, C. / Armand, J. P. / De Andreis, D. / Ropert, S. / Lopez, E. / Catteau, A. / James, J. / Marier, J. F. et al. | 2012
- 472
-
Survival from common and rare cancers in Germany in the early 21st centuryHiripi, E. / Gondos, A. / Emrich, K. / Holleczek, B. / Katalinic, A. / Luttmann, S. / Sirri, E. / Brenner, H. et al. | 2012
- 479
-
Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in JapanMatsuo, K. / Mizoue, T. / Tanaka, K. / Tsuji, I. / Sugawara, Y. / Sasazuki, S. / Nagata, C. / Tamakoshi, A. / Wakai, K. / Inoue, M. et al. | 2012
- 491
-
Dietary cholesterol intake and cancerHu, J. / La Vecchia, C. / de Groh, M. / Negri, E. / Morrison, H. / Mery, L. et al. | 2012
- 501
-
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer NetworkStacchiotti, S. / Palassini, E. / Sanfilippo, R. / Vincenzi, B. / Arena, M. G. / Bochicchio, A. M. / De Rosa, P. / Nuzzo, A. / Turano, S. / Morosi, C. et al. | 2012
- 508
-
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyGrignani, G. / Palmerini, E. / Dileo, P. / Asaftei, S. D. / D'Ambrosio, L. / Pignochino, Y. / Mercuri, M. / Picci, P. / Fagioli, F. / Casali, P. G. et al. | 2012
- 517
-
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomePenel, N. / Italiano, A. / Ray-Coquard, I. / Chaigneau, L. / Delcambre, C. / Robin, Y. M. / Bui, B. / Bertucci, F. / Isambert, N. / Cupissol, D. et al. | 2012
- 524
-
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989Hollestein, L. M. / van den Akker, S. A. / Nijsten, T. / Karim-Kos, H. E. / Coebergh, J. W. / de Vries, E. et al. | 2012
- 531
-
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)von Moos, R. / Seifert, B. / Simcock, M. / Goldinger, S. M. / Gillessen, S. / Ochsenbein, A. / Michielin, O. / Cathomas, R. / Schlappi, M. / Moch, H. et al. | 2012
- 537
-
Toxicity burden score: a novel approach to summarize multiple toxic effectsLee, S. M. / Hershman, D. L. / Martin, P. / Leonard, J. P. / Cheung, Y. K. et al. | 2012
- 542
-
Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse dataOjha, R. P. / Thertulien, R. et al. | 2012
- 543
-
"The only thing I know is that I know nothing": 5-fluorouracil in human milkPeccatori, F. A. / Giovannetti, E. / Pistilli, B. / Bellettini, G. / Codacci-Pisanelli, G. / Losekoot, N. / Curigliano, G. / Azim, H. A. / Goldhirsch, A. / Peters, G. J. et al. | 2012